Life Sciences Consulting and Advisory Services
Catalyzing innovation and growth in life sciences.
Who We Are
Years of Experience
In transaction and advisory roles
In M&A and Licensing
Deals completed with an investor viewpoint
Capital Raised
For life sciences companies
Dedicated Life Sciences Corporate Development and Venture Strategy firm
Experience across biotech, techbio, medtech, and adjacent sectors
Investor Viewpoint and Analysis
Strategic insights for informed decision-making
Capital Formation Expertise
Guidance for companies during successful funding rounds
Operator Mindset and Actionability
Interim CBO and BD leadership roles for venture-backed and public companies
Our Philosophy
Move Fast:
deliver actionable outputs in less than 90 days
Scoped Engagements:
focus on defined outcomes, not open-ended consulting
Strategy + Execution:
deliver deal-ready materials, not just analysis
Investor Viewpoint + Operator Mindset:
align corporate development with financing and growth strategy
Core Offerings
Sprint Engagements
Rapid 6–12 week engagements to get BD-ready (partner scan, deal positioning, investor/partner decks)
Project Engagements
Broader 3–4 month corp dev initiatives (landscaping, buy-side/in-licensing sell-side/out-licensing filters, pipeline prioritization)
Due Diligence
Independent technical, financial, and market diligence (asset valuation, competitive benchmarking, risk assessment)
Retainer Advisory
Ongoing strategic and BD support (monthly strategy cadence, introductions, investor messaging, transaction preparation)
Interim CBO
Fractional executive leadership (end-to-end BD process management, licensing negotiations, fundraising support, board engagement)
Flexible Options
Hybrid (Sprint → Retainer)
Start with a sprint, transition into ongoing support as the relationship deepens
Advisory / Strategic Counsel
Light-touch engagement for partnerships, strategic insight, and network leverage
Long-term Support
Start with a success BD project and see it through to completion of transaction with integration support.
Why Bellows
Fast & Lean
specific outputs in weeks, not quarters
Life Sciences specialists
deep domain knowledge in biotech, techbio, and medtech
Flexible Structures
sprint, project, interim, and advisory models adapt to company stage and need
Investor Viewpoint: first-principles analysis
and direct deal track record
Operator Mindset: practical deliverables
decks, models, and scenarios immediately usable in investor and partner meetings
Example Next Steps
Scope a sprint or diligence engagement before JPM 2026
Equip your team with partner scans, opportunity analyses, BD decks, and deal scenarios to maximize conference 1:1s
Build momentum for licensing, partnerships, or financing events in 2026
Contact Us
Bellows Capital Partners
William Grenawitzke william@bellowscapital.com
Los Angeles
Santa Monica, CA 90405
Ann Arbor
Ann Arbor, MI 48105
New York
New York, NY 10014
Bellows Capital Partners